SEC Form 4 · accession 0000899243-18-006476
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2018 | M | 26,992 | $2.64 | A | 44,860 | D | |
| Common StockF2 | holding | — | — | — | 349,190 | I | By Trust | |
| Common Stock | holding | — | — | — | 21,000 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $2.64 | Mar 2, 2018 | M | 26,992 | D | — | Dec 16, 2023 | Common Stock | 26,992 | 9,729 | D |
| Employee Stock Option (Right to Buy)F3 | $2.64 | Mar 2, 2018 | M | 6,798 | D | — | Dec 16, 2023 | Common Stock | 6,798 | 0 | I |
Explanation of responses
- F1Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017.
- F2Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee.
- F31/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.